Who has invested in Nudge?

Thrive Capital, Greenoaks are named among the investors backing Nudge.

Nudge Funding: $100M Raised, Series A (2025)

Nudge funding overview

Nudge is a Biotech company based in San Francisco. Nudge has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in July 2025. The round record for Nudge runs through 2025; nothing later has been disclosed. Investors on record include Thrive Capital, Greenoaks. 2 distinct backers are named across the disclosed rounds.

Nudge at a glance

Total raised: $100M
Latest round: Series A
Latest round date: July 2025
Industry: Biotech
Headquarters: San Francisco
Notable investors: Thrive Capital, Greenoaks

Frequently asked about Nudge funding

How much has Nudge raised?: Nudge has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Nudge?: Thrive Capital, Greenoaks are named among the investors backing Nudge.
What was the latest Nudge funding round?: The most recent disclosed round is a Series A, announced in July 2025.
Where is Nudge based?: Nudge is based in San Francisco.
What sector does Nudge operate in?: Nudge is tracked under Biotech from San Francisco, with $100M in disclosed funding.
When did Nudge last raise?: The last disclosed Nudge round closed in July 2025 at Series A.

Round data for Nudge is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in San Francisco and backer lists below.

Nudge Funding: $100M Raised, Series A (2025)

Nudge funding overview

Nudge at a glance

Frequently asked about Nudge funding

Companies related to Nudge (40)

Browse related funding lists (7)